首页 | 本学科首页   官方微博 | 高级检索  
     


Contrast-enhanced sonography of pancreatic ductal carcinoma using agent detection imaging
Authors:Naohiro Ichino  Yuji Horiguchi  Hideo Imai  Keisuke Osakabe  Tohru Nishikawa  Yukiko Sugita  Hideko Utsugi  Yoko Togo  Tomoko Sawai  Yoshikazu Mizoguchi
Affiliation:(1) Department of Clinical Physiology, School of Health Sciences, Fujita Health University, Aichi, Japan;(2) Department of Gastroenterology, School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan;(3) Department of Medical Imaging Laboratory, Fujita Health University College, Aichi, Japan;(4) Department of Clinical Laboratory, Fujita Health University Hospital, Aichi, Japan;(5) Department of Radiology, Fujita Health University Hospital, Aichi, Japan;(6) Department of Pathology, School of Medicine, Fujita Health University, Aichi, Japan
Abstract:Purpose The aim of this study was to evaluate the enhancement behavior of pancreatic ductal carcinoma by contrast-enhanced sonography with agent detection imaging (ADI), and to clarify the origin of microbubble signals by comparisons with histological findings of resected specimens. Methods The subjects were 21 patients with resectable pancreatic carcinoma. The final histological diagnosis was tubular adenocarcinoma in 20 cases, and anaplastic carcinoma in one case. Ultrasound examinations were performed using an Acuson Sequoia 512 series system, and the contrast agent (Levovist) was injected intravenously in doses of 7 ml (300 mg/ml). The ADI signals (in the tumor) were recorded continuously for 30 s after an injection of Levovist (vascular image) and then obtained intermittently (30 s time-intervals) until the signal had diminished in pancreatic tissue (perfusion image). Results Contrast enhancement of the tumor was observed in 71.4% of subjects on the vascular image and 76.3% of subjects on the perfusion image. Enhancement patterns on the vascular image were classified into three types: VI-1 (linear enhancement), VI-2 (spotty enhancement), and VI-3 (no enhancement). VI-1, VI-2, and VI-3 were seen in 9 (42.8%), 6 (28.6%), and 6 (28.6%) of the 21 cases, respectively. Enhancement patterns on the perfusion image were classified into four types: PI-1 (diffuse uneven enhancement), PI-2 (spotty enhancement), PI-3 (peripheral enhancement), and PI-4 (negative enhancement). The incidence of PI-1, PI-2, PI-3, and PI-4 was 4.8%, 42.9%, 28.6%, and 23.8%, respectively. With respect to resectable cases, these enhancement patterns were compared with histological findings, i.e., the distribution of blood vessels in the tumor, remaining pancreatic tissues in the tumor, differentiation of types of adenocarcinoma, volume of stroma, and invasion types of carcinoma. The enhanced patterns consequently corresponded to either the distribution of the blood vessels or the remaining pancreatic tissues in the tumor. Conclusion This study indicated that pancreatic ductal carcinoma is frequently enhanced by microbubbles, and the signals seem to originate from fine blood vessels and the remaining pancreatic tissues in the tumor.
Keywords:pancreatic ductal carcinoma  contrast-enhanced sonography  agent detection imaging, Levovist
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号